The strong performance of GSK will be seen as an endorsement of Walmsley’s decision to split the business two years ago. It was split into a vaccine and advanced healthcare wing – GSK – and ...
January 13, 2025--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based ...
GSK Plc (NYSE:GSK) reported fourth-quarter sales of $10.40 billion (8.12 billion Sterling Pounds), up 1% year-over-year and ...
DAVENPORT & Co LLC lessened its position in shares of GSK plc (NYSE:GSK – Free Report) by 4.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission.
Following GSK’s deal-heavy end to 2024, Chief Scientific Officer Tony Wood, Ph.D., doesn’t expect the trend to let up in the new year, zeroing in on partnerships that can expand knowledge ...
GlaxoSmithKline PLC on Tuesday said the new company resulting from the proposed demerger of its Consumer Healthcare a ... Subscribe now to see this Premium News article from Alliance News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results